Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open Label, two-treatment, two-period, two-sequence, crossover, single
dose pivotal study. The purpose of this study is to assess the bioequivalence between Test
Product and the corresponding Reference Product under fasting condition in normal, healthy,
adult, human subjects.